Announcements Trials

Browse Landscape

Phase

Status

Completed 75 Recruiting 68 Active not recruiting 42 Terminated 28 Not yet recruiting 9 Unknown 8 Withdrawn 4 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 8 Vincristine 7 Prednisone 6 Specimen Handling 5 Rituximab 5 Doxorubicin 5 zanubrutinib 3 prednylidene 3 deltacortene 3 Magnetic Resonance Spectroscopy 3 tazemetostat 2 fludarabine phosphate 2 fludarabine 2 Radiotherapy, Intensity-Modulated 2 Melphalan 2 Etoposide 2 Drug Therapy 2 CT-P10 2 Biopsy 2 Azacitidine 2 Antibodies, Monoclonal 2 vactosertib 1 tisagenlecleucel 1 sargramostim 1 ponatinib 1 pembrolizumab 1 obinutuzumab 1 mogamulizumab 1 glucarpidase 1 duvelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × obinutuzumab × Lymphoid × Clear all

NCT06824701 2026-04-06

TARZAN

University of Utah

Phase 1 Suspended

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡